ad image

Biotech

1 / 3
Five Small Biotechs to Watch: March 2025
Small Biotechs

Five Small Biotechs to Watch: March 2025

David Alvaro, Ph.D.

Pharma's Almanac

PAO-02-25-NI-06Feb 28, 2025
Five Small Biotechs to Watch: February 2025
Biotechs

Five Small Biotechs to Watch: February 2025

David Alvaro, Ph.D.

Pharma's Almanac

PAO-02-25-NI-01Feb 03, 2025
CellFE
Announcement

CellFE® Announces Strategic Placements with Leading Pharma and Biotech Companies

CellFE

PR-12-24-NI-143Dec 19, 2024
Adapting Medical Information Services to Japan’s Distinct Needs
Regulatory

Adapting Medical Information Services to Japan’s Distinct Needs

Jim Leaver, Ph.D.

PrimeVigilance

PAO-11-24-CL-03Nov 22, 2024
SynaptixBio
Gene Silencing

‘Gene silencing’ therapies market set to boom, says leading biotech

SynaptixBio

PR-11-24-NI-115Nov 20, 2024
Atlas Venture
biotechnology

Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise

Atlas Venture

PR-11-24-NI-111Nov 18, 2024
Neurocrine Biosciences
Bioscience

Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules

Neurocrine Biosciences

PR-10-24-NI-71Nov 04, 2024
Biotech Funding Ups and Downs
Nice Insight Reports

Biotech Funding Ups and Downs

April Stanley, MS MBA

Nice Insight

PAO-04-24-NI-01Apr 02, 2024
Wheeler Bio

Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC

Wheeler Bio

PR-M11-23-01Nov 08, 2023
Wheeler Bio

Wheeler Bio Announces Grand Opening of Biomanufacturing Facility

Wheeler Bio

PR-M10-23-01Oct 05, 2023
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Immuno-Oncology

Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology

Dan Passeri, M.Sc., J.D.

Cue Biopharma

PAO-12-022-CL-01Jan 04, 2023
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Synthetic Biology

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

PAO-12-022-NI-01Dec 23, 2022
Digital Therapeutics and the Song of the Future of Healthcare
Digital Therapeutics

Digital Therapeutics and the Song of the Future of Healthcare

Chris E. Rivera; Xavier A. Figueroa

EMulate Therapeutics

PAO-12-022-CL-02Dec 20, 2022
Stopping Bleeds and Saving Lives
Hemostatic

Stopping Bleeds and Saving Lives

Joe Landolina

Cresilon

PAO-11-022-CL-09Nov 16, 2022
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Plant-Inspired Drug Discovery

Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures

Andrea Small-Howard, Ph.D.

Gb Sciences, Inc.

PAO-08-022-CL-01Sep 06, 2022
Life Science Industrials Are Key to the Growth of the Biopharma Industry
Life Science Industrials

Life Science Industrials Are Key to the Growth of the Biopharma Industry

Reinhard Vogt

Dynamk Capital

PAO-07-022-CL-05Aug 04, 2022
Olon
New Division

Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes

Olon

PR-M07-22-03Jul 12, 2022
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Column: Investment

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-02Jun 24, 2022
10 More Biotechs Making Moves in 2022
Biotechs

10 More Biotechs Making Moves in 2022

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-07Jun 24, 2022
Enabling Drug Discovery Targeting Ion Channels

Enabling Drug Discovery Targeting Ion Channels

Doug Krafte, Ph.D.

Icagen

Ion ChannelsMay 19, 2022
1 / 3